A Multicenter, Randomized Controlled Study of the Efficacy of Once-Weekly DPP-4 Inhibitor Omarigliptin in Patients with Type 2 Diabetes Undergoing Maintenance Hemodialysis

被引：0
|
作者：
Yoshizawa, Yuta
Hosojima, Michihiro
Kabasawa, Hideyuki
Tanabe, Naohito
Kitamura, Tadahiro
Narita, Ichiei
Saito, Akihiko
机构：
来源：
DIABETES | 2019年 / 68卷
关键词：
D O I：
10.2337/db19-29-LB
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
29-LB
引用
收藏
页数：2
相关论文
共 50 条
  • [11] Omarigliptin, a once-weekly DPP-4 inhibitor, provides similar glycaemic control to sitagliptin in patients with type 2 diabetes mellitus inadequately controlled on metformin
    Gantz, I.
    Lai, E.
    Suryawanshi, S.
    Andryuk, P.
    Engel, S. S.
    DIABETOLOGIA, 2015, 58 : S54 - S55
  • [12] Effect of omarigliptin, a novel once-weekly DPP-4 inhibitor, in Japanese patients with type 2 diabetes: a placebo- and sitagliptin-controlled trial
    Gantz, I.
    Okamoto, T.
    Ito, Y.
    Okuyama, K.
    Engel, S. S.
    DIABETOLOGIA, 2014, 57 : S55 - S55
  • [13] Efficacy of omarigliptin, once-weekly dipeptidyl peptidase-4 inhibitor, in patients with type 2 diabetes
    Kawasaki, Eiji
    Nakano, Yuko
    Fukuyama, Takahiro
    Uchida, Aira
    Sagara, Yoko
    Tamai, Hidekazu
    Tojikubo, Masayuki
    Hiromatsu, Yuji
    Koga, Nobuhiko
    WORLD JOURNAL OF DIABETES, 2021, 12 (12) : 2087 - 2095
  • [14] Omarigliptin, a Once-Weekly DPP-4 Inhibitor, Improves Glycemic Control in Patients Inadequately Controlled on the Combination of Metformin and Glimepiride
    Lee, Seung-Hwan
    Gantz, Ira
    Round, Elizabeth
    O'Neill, Edward A.
    Latham, Melanie
    Ceesay, Paulette
    Suryawanshi, Shailaja
    Lai, Eseng
    DIABETES, 2016, 65 : A50 - A50
  • [15] A randomised, double-blind, trial of the safety and efficacy of omarigliptin (a once-weekly DPP-4 inhibitor) in subjects with type 2 diabetes and renal impairment
    Chacra, Antonio
    Gantz, Ira
    Mendizabal, Geraldine
    Durlach, Lucila
    O'Neill, Edward A.
    Zimmer, Zachary
    Suryawanshi, Shailaja
    Engel, Samuel S.
    Lai, Eseng
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2017, 71 (06)
  • [16] Omarigliptin (MK-3102): A Novel Long-Acting DPP-4 Inhibitor for Once-Weekly Treatment of Type 2 Diabetes
    Biftu, Tesfaye
    Sinha-Roy, Ranabir
    Chen, Ping
    Qian, Xiaoxia
    Feng, Dennis
    Kuethe, Jeffrey T.
    Scapin, Giovanna
    Gao, Ying Duo
    Tan, Youwei
    Krueger, Davida
    Bak, Annette
    Eiermann, George
    He, Jiafang
    Cox, Jason
    Hicks, Jacqueline
    Lyons, Kathy
    He, Huaibing
    Salituro, Gino
    Tong, Sharon
    Patel, Sangita
    Doss, George
    Petrov, Aleksandr
    Wu, Joseph
    Xu, Shiyao Sherrie
    Sewall, Charles
    Zhang, Xiaoping
    Zhang, Bei
    Thornberry, Nancy A.
    Weber, Ann E.
    JOURNAL OF MEDICINAL CHEMISTRY, 2014, 57 (08) : 3205 - 3212
  • [17] Once-Weekly Treatment with Omarigliptin, a DPP-4 Inhibitor, Improves Glycemic Control in Patients Not at Goal on Metformin
    Shankar, R. Ravi
    Inzucchi, Silvio E.
    Gantz, Ira
    O'Neill, Edward A.
    Scarabello, Victoria
    Ceesay, Paulette
    Suryawanshi, Shailaja
    Lai, Eseng
    DIABETES, 2016, 65 : A293 - A293
  • [18] MK-3102 (omarigliptin): A novel DPP-4 inhibitor for once weekly treatment of type 2 diabetes
    Biftu, Tesfaye
    Chen, Ping
    Qian, Xiaoxia
    Feng, Dennis
    Cox, Jason
    Hicks, Jacqueline
    Sinha-Roy, Ranabir
    Scapin, Giovanna
    Gao, Ying-Duo
    Eiermann, George
    He, Jiafang
    He, Huaibing
    Kuethe, Jeffery
    Lyons, Kathy
    Salituro, Gino
    Patel, Sangita
    Petrov, Aleksandr
    Wu, Joseph
    Zhang, Xiaoping
    Zhang, Bei
    Weber, Ann
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2013, 246
  • [19] A randomized, double-blind, non-inferiority trial evaluating the efficacy and safety of omarigliptin, a once-weekly DPP-4 inhibitor, or glimepiride in patients with type 2 diabetes inadequately controlled on metformin monotherapy
    Handelsman, Yehuda
    Lauring, Brett
    Gantz, Ira
    Iredale, Carol
    O'Neill, Edward A.
    Wei, Ziwen
    Suryawanshi, Shailaja
    Kaufman, Keith D.
    Engel, Samuel S.
    Lai, Eseng
    CURRENT MEDICAL RESEARCH AND OPINION, 2017, 33 (10) : 1861 - 1868
  • [20] Efficacy and safety of once-weekly GLP-1 RA in patients with type 2 diabetes treated with DPP-4 inhibitor
    Murakami, Masako
    Hirahara, Naoko
    Morita, Hiroshi
    Sasaki, Shigekazu
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2016, 120 : S105 - S105
12345